Emflaza
Deflazacort
Emflaza es un corticosteroide elaborado para el tratamiento de la distrofia muscular de Duchenne (DMD) para los pacientes de 5 años o más.
more
| Empaquetado | Per comprimido | Precio | Ahorro | Order |
|---|---|---|---|---|
|
120 tablet
Free AirMail shipping
Hot
|
$ 4.58
|
$ 549.95$ 4.58
|
$ 99.80
|
|
|
90 tablet
Free AirMail shipping
Hot
|
$ 4.83
|
$ 434.95$ 4.83
|
$ 52.36
|
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 5.00
|
$ 299.95$ 5.00
|
$ 24.93
|
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 5.28
|
$ 189.95$ 5.28
|
$ 4.97
|
|
|
24 tablet
|
$ 5.41
|
$ 129.95$ 5.41
|
|
| Empaquetado | Per comprimido | Precio | Ahorro | Order |
|---|---|---|---|---|
|
90 tablet
Free AirMail shipping
Hot
|
$ 5.55
|
$ 499.95$ 5.55
|
$ 99.86
|
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 6.00
|
$ 359.95$ 6.00
|
$ 39.93
|
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 6.39
|
$ 229.95$ 6.39
|
$ 9.97
|
|
|
24 tablet
Free AirMail shipping
Hot
|
$ 6.66
|
$ 159.95$ 6.66
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
